Gilde Healthcare has taken another step – the second in two weeks and the third this year – in pursuing its strategy to build out its European its specialist MedTech CDMO, Surgical Precision Instruments (SPI), with the acquisition of Germany-based Hermann Medizintechnik.
“With their outstanding manufacturing expertise, long-standing customer relationships and complementary product portfolio, Hermann is an ideal fit for SPI and we are excited to welcome them to the group,” said Rafael Natanek, general partner at Gilde Healthcare.
With the addition of Hermann, SPI grows to more than 500 highly skilled employees across seven sites in the DACH region, with the group approaching €100m in sales. Gilde intends to continue expanding SPI through both strategic acquisitions and organic growth as consolidation in the surgical instrument manufacturing sector accelerates.
“Hermann Medizintechnik reinforces our position as a comprehensive partner to our customers and extends our portfolio across an even broader set of surgical specialties and therapeutic areas,” said Dr Christian Stark, CEO of SPI.
Hermann develops and manufactures complex surgical instruments and implants. Its portfolio ranges from a broad range of implant systems through to customised special instruments for a wide variety of surgical disciplines.
“After more than sixty years as a family business, we are becoming part of a group that shares our understanding of precision manufacturing – with the scale and resources to support our next phase of growth,” said Florian Hermann, managing director of Hermann. “Joining SPI opens an exciting new chapter for us.”
Gilde Healthcare established SPI with the acquisitions of Chr Diener in 2022, Koscher & Würtz in 2023, Rudischhauser and BENTEC in 2026.
